Overview
Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients
Status:
Completed
Completed
Trial end date:
2013-01-01
2013-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
In this trial the safety, tolerability, pharmacokinetics and exploratory pharmacodynamics of multiple dose administration of BI 144807 will be investigated in otherwise healthy, controlled asthmatic patientsPhase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Boehringer Ingelheim
Criteria
Inclusion criteria:1. mild asthmatic, otherwise healthy subjects (male and female of non-childbearing
potential)
Exclusion criteria:
1. Apart from mild asthma any relevant deviation from healthy conditions